Physical 32.1% 5 % relative 15% relative Prevalence of WHO STEPS inactivity reduction reduction insufficiently physically (28.9% ) active among adults (30.5% ) Salt/sodium 12.8 g/day 20% relative 30% relative reduction Mean population intake Appropriate intake reduction (9.0 g/ day) of salt in persons aged method should (10.0 g/ day) 18+ years be developed Tobacco use 24.4% 10% relative 20% relative reduction Prevalence of current WHO STEPS reduction (20 %) tobacco use adults (22.0 %) Raised blood 39% 15% relative 25% relative Prevalence of raised WHO STEPS Pressure reduction reduction blood pressure among (33%) (30%) adults Diabetes and 17.2% Halt the rise in Halt the rise in Prevalence of raised WHO obesity diabetes diabetes & obesity diabetes & obesity blood glucose/diabetes 31.3% and obesity among Obesity adults Drug therapy to N/A* 10 % coverage 15 % coverage Proportion of eligible Appropriate prevent CVD % persons receiving method should preventive therapy be developed Essential NCDs 60% 70% availability 80% availability Coverage of essential Appropriate NCDs medicines and method should medicines and basic technologies basic technology in be developed to treat major PHC. NCDs *As is currently no available baseline data, the approach will be piloted in selected PHC settings.
Physical inactivity 32.1% 5 % relative reduction (30.5% ) 15% relative reduction (28.9% ) Prevalence of insufficiently physically active among adults WHO STEPS Salt/sodium intake 12.8 g/day 20% relative reduction (10.0 g/ day) 30% relative reduction (9.0 g/ day) Mean population intake of salt in persons aged 18+ years Appropriate method should be developed Tobacco use 24.4% 10% relative reduction (22.0 %) 20% relative reduction (20 %) Prevalence of current tobacco use adults WHO STEPS Raised blood Pressure 39% 15% relative reduction (33%) 25% relative reduction (30%) Prevalence of raised blood pressure among adults WHO STEPS Diabetes and obesity 17.2% diabetes 31.3% Obesity Halt the rise in diabetes & obesity Halt the rise in diabetes & obesity Prevalence of raised blood glucose/diabetes and obesity among adults WHO Drug therapy to prevent CVD N/A* % 10 % coverage 15 % coverage Proportion of eligible persons receiving preventive therapy Appropriate method should be developed Essential NCDs medicines and basic technologies to treat major NCDs 60% 70% availability 80% availability Coverage of essential NCDs medicines and basic technology in PHC. Appropriate method should be developed *As is currently no available baseline data, the approach will be piloted in selected PHC settings.
EGY_B3_NCDMAPEgypt21March2017%20FINAL%20%20RS.docx